Drugs / Jingfang Granules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07688161 | Jul 2026 → Jan 2028 expected | irritable bowel syndrome | Nanjing First Hospital, Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jingfang Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07688161 ↗ |
| Route | Oral | “Oral administration of Jingfang Granules” NCT07688161 ↗ |